Every Form 4 that Elanco Animal Health Incorporated (ELAN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ELAN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ELAN filings page.
Elanco Animal Health Inc. (ELAN) Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 62.7147 deferred stock units in a grant or award transaction on October 16, 2026, reported at $23.5500 per unit. His reported post-transaction position was 10,025.8941 deferred stock units held directly.
Each deferred stock unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc President, CEO and director Jeffrey N. Simmons acquired 120.0395 deferred stock units on October 16, 2026, reported at $23.55 per unit. His directly held balance after the acquisition was 25,619.3221 deferred stock units. Each unit represents the right to receive one share of common stock or its cash equivalent; units settle following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.
Elanco Animal Health Inc EVP and CFO Robert M. VanHimbergen acquired 8.3660 deferred stock units as an award on October 16, 2026; his reported direct balance afterward was 175.9183 units. Each unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc (ELAN) officer Timothy J. Bettington, Executive Vice President, Center of Strategic Growth, sold 4,350 common shares on October 15, 2026, at $23 per share. The sale was made under a Rule 10b5-1 trading plan adopted June 15, 2026. He directly held 138,911 shares following the transaction.
Elanco Animal Health Inc (ELAN) Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 66.7087 deferred stock units on October 2, 2026. The reported per-unit price was $22.1400, and his directly held balance following the acquisition was 9,963.1794 deferred stock units. Each unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc (ELAN) President, CEO and Director Jeffrey N. Simmons acquired 127.6843 deferred stock units on October 2, 2026, as a grant. His reported direct holdings after the transaction were 25,499.2826 deferred stock units. Each unit represents the right to receive one share of company common stock or its cash equivalent; units settle following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.
Elanco Animal Health Inc. EVP and CFO Robert M. VanHimbergen acquired 8.8988 deferred stock units on October 2, 2026, at a reported price of $22.14 per unit. His directly held position was 167.5523 deferred stock units following the transaction. Each unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc. director Kapila K. Anand acquired 642.0277 deferred stock units on September 30, 2026, after electing to defer director cash retainer fees under the Directors' Deferral Plan. Each unit is the economic equivalent of one common share. Her reported holdings after the transaction were 10,721.5916 deferred stock units. The unit count is calculated by dividing deferred cash compensation by the $24.61 closing share price on the grant date.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that President, CEO and Director Jeffrey N. Simmons received a grant of 126.0897 Deferred Stock Units on September 18, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Simmons directly holds 25,371.5983 Deferred Stock Units; no Rule 10b5-1 trading plan is reported.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi received an equity-based award of 65.8756 Deferred Stock Units on September 18, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent and is scheduled to settle in cash or shares after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan. Following this award, Modi holds a total of 9,896.4707 Deferred Stock Units directly.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that EVP and CFO Robert M. VanHimbergen received a grant of 8.7877 Deferred Stock Units on September 18, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent, generally settling after employment termination or in a specified future year. Following this award, he holds 158.6535 Deferred Stock Units directly.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that its EVP and CFO, Robert M. VanHimbergen, received a grant of 8.0416 Deferred Stock Units on September 4, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent, bringing his directly held deferred stock units to 149.8658.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that executive Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation, received a grant of 60.2829 Deferred Stock Units on September 4, 2026. Following this award, he holds 9,830.5951 Deferred Stock Units directly.
Each Deferred Stock Unit represents the right to receive one share of Elanco common stock or the cash equivalent, settling in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that President and CEO Jeffrey N. Simmons received a grant of 115.3849 Deferred Stock Units on September 4, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan. Following this award, Simmons holds 25,245.5086 Deferred Stock Units directly.
Elanco Animal Health Inc (ELAN) reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 61.6158 Deferred Stock Units on 2026-08-21 as a grant or award. Each unit corresponds to one share of common stock or the cash equivalent and will settle in cash or shares after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Modi holds a total of 9,770.3122 Deferred Stock Units directly.
Elanco Animal Health Inc (ELAN) reported that EVP and CFO Robert M. VanHimbergen acquired 8.2194 Deferred Stock Units on 2026-08-21 as a grant/award. Each unit corresponds to one share of common stock or the cash equivalent and will settle in cash or shares after employment ends or in a specified future year. Following this award, he directly holds 141.8242 Deferred Stock Units.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC.
Elanco Animal Health Inc (ELAN) director Lawrence Erik Kurzius reported an open-market purchase of 40,000 shares of common stock on August 20, 2026 at a weighted average price of $23.398 per share, with individual trades ranging from $23.385 to $23.40. Following these purchases, his reported direct holdings increased to 188,647 shares of Elanco common stock.
Elanco Animal Health Inc (ELAN) reported that officer Shiv O'Neill, General Counsel and Corporate Secretary, purchased 3,998 shares of common stock on 2026-08-18 at $23.58 per share in an open-market or private transaction. After this trade, O'Neill directly holds 87,832 shares of Elanco common stock. The transaction was not made pursuant to a Rule 10b5-1 trading plan.
Elanco Animal Health Inc director Michael J. Harrington purchased 5,000 shares of common stock on 2026-08-12 in an open market or private transaction at a price of $21.82 per share. Following this transaction, his directly held position increased to 131,451 shares of Elanco common stock.
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that President, CEO and Director Jeffrey N. Simmons received a grant of 127.7997 Deferred Stock Units on 2026-08-07 at a reference value of $22.12 per unit. Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Simmons holds 25,012.1875 Deferred Stock Units directly.
Elanco Animal Health EVP and CFO Robert M. VanHimbergen reported two transactions on August 7, 2026. He received a grant of 8.9069 Deferred Stock Units, each representing the right to one share of common stock or cash, bringing his Deferred Stock Unit balance to 133.6048. On the same date, he purchased 4,200 shares of common stock in multiple transactions at a weighted average price of $23.0776 per share, with individual prices ranging from $23.01 to $23.09. Following these purchases, he directly owns 137,516 shares of Elanco Animal Health common stock.
Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi received a grant of 66.7690 Deferred Stock Units tied to Company common stock at a reference price of $22.1200 per unit. Each unit represents the right to receive one share of common stock or the cash equivalent, settling in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Modi holds a total of 9708.6964 Deferred Stock Units directly.
Elanco Animal Health Inc director Paul Herendeen reported an open-market purchase of 10,000 shares of Common Stock on August 7, 2026 at $23.685 per share. Following this transaction, his reported direct ownership increased to 111,687 common shares of Elanco Animal Health Inc.
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that President, CEO and Director Jeffrey N. Simmons received a grant of 113.4857 deferred stock units on 2026-07-24 at $24.9100 per unit, increasing his direct deferred stock unit holdings to 24,884.3878 units. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares after termination of employment or in a specified future year under the company’s Executive Deferral and Stock Match Plan.
Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi received a grant of 59.2906 deferred stock units on 2026-07-24 at a reference value of $24.91 per unit. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. Following this grant, Modi holds 9,641.9274 deferred stock units directly.
VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that EVP and CFO Robert M. VanHimbergen received a grant of 7.9093 deferred stock units on July 24, 2026 at $24.91 per unit. Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. After this compensation-related grant, he holds 124.6979 deferred stock units directly.
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc’s president, CEO and director Jeffrey N. Simmons received a grant of 113.8973 deferred stock units on July 10, 2026, referenced at $24.8200 per unit. Following this award, he holds 24,770.9021 deferred stock units directly.
Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares after termination of employment, or in a specified future year, under the Executive Deferral and Stock Match Plan.
VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health’s EVP and CFO, Robert M. VanHimbergen, received a grant of 7.9380 deferred stock units on 2026-07-10 at a reference value of $24.8200 per unit. Each unit represents the right to receive one share of common stock or the cash equivalent under the Executive Deferral and Stock Match Plan and will settle after employment ends or in a specified future year. Following this award, he holds 116.7886 deferred stock units directly.
Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc company officer Rajeev A. Modi received a grant of 59.5056 deferred stock units on July 10, 2026 at a reference price of $24.82 per unit. Each unit represents the right to one share of common stock or the cash equivalent and will settle after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Modi directly holds 9,582.6368 deferred stock units.
Elanco Animal Health EVP and CFO Robert M. VanHimbergen reported a tax-related share disposition. On this Form 4, 15,336 shares of Common Stock were used at $24.64 per share to satisfy tax obligations by delivering shares to the issuer. After this tax-withholding disposition, he directly holds 133,316 shares of Elanco common stock, indicating the event is compensation- and tax-driven rather than an open-market trade.
Elanco Animal Health executive David S. Kinard received a grant of employee stock options, giving him rights to buy 25,620 shares of common stock at an exercise price of $24.09 per share. These options vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, and expire on July 1, 2036. Following this grant, Kinard holds 25,620 stock options directly.
Anand Kapila K reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health director K. Anand reported receiving 584.1121 Deferred Stock Units on June 30, 2026. These units were issued at an implied price of $24.61 per unit by deferring her director cash retainer into the company’s Directors’ Deferral Plan.
Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock and will be settled in stock when she leaves the Board. Following this compensation-related award, Anand holds a total of 10,079.5639 Deferred Stock Units directly.
Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health reported that executive Rajeev A. Modi received a grant of 60.1111 deferred stock units on June 26, 2026, each tied to Company common stock at a reference price of $24.57 per unit. After this award, he holds 9,523.1312 deferred stock units in total.
Each deferred stock unit represents the right to receive either one share of Elanco common stock or the cash equivalent. These units are scheduled to settle in cash or shares after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan.
Elanco Animal Health Inc reported that President and CEO Jeffrey N. Simmons received a grant of deferred stock units under a compensation plan. The award covers 115.0562 deferred stock units, each linked to one share of Elanco common stock or its cash equivalent at a reference value of $24.57 per unit.
Following this award, Simmons holds a total of 24,657.0048 deferred stock units directly. These units are designed to settle in cash or company shares after his employment ends or in a specified future year, in line with the Executive Deferral and Stock Match Plan, making this a routine, non-market, compensation-related acquisition rather than an open-market purchase.
VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health EVP and CFO Robert M. VanHimbergen received a grant of 8.0187 deferred stock units tied to Elanco common stock at a reference price of $24.57 per unit. Following this award, he holds 108.8506 deferred stock units, which will settle in cash or shares after employment ends or in a specified future year.
VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health EVP and CFO Robert M. VanHimbergen received a grant of 8.1514 deferred stock units of Elanco common stock at a reference price of $24.17 per unit. Following this grant, he holds 100.8319 deferred stock units directly.
Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. These units settle in cash or shares after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan.
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health President and CEO Jeffrey N. Simmons reported a routine compensation-related transaction involving deferred stock units. He received an award of 116.9603 deferred stock units, each tied to the value of one share of Elanco common stock at a reference price of $24.17 per unit.
After this grant, his reported balance of deferred stock units increased to 24,541.9486 units. According to the plan terms, these units will settle in either cash or Elanco common shares after his employment ends or in a specified future year under the Executive Deferral and Stock Match Plan.
Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that executive Rajeev A. Modi received a grant of 61.1059 deferred stock units tied to Elanco common stock. Each unit reflects a value of $24.17 per underlying share in the filing.
Following this award, Modi holds a total of 9,463.0201 deferred stock units directly. According to the plan terms, these units will settle in either cash or Elanco common shares after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan.
VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health EVP and CFO Robert M. VanHimbergen reported a routine compensation-related award of deferred stock units. He received 8.2608 deferred stock units, each tied to one share of common stock at a reference price of $23.85, bringing his total deferred stock units to 92.6805. These units will be settled in cash or Elanco common stock after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan.
Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that officer Rajeev A. Modi received a grant of deferred stock units under a company plan. The award covers 61.9258 deferred stock units tied to Elanco common stock at a reference price of $23.85 per unit.
Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent, according to the company’s Executive Deferral and Stock Match Plan. After this grant, Modi holds a total of 9,401.9142 deferred stock units directly.
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health President and CEO Jeffrey N. Simmons received a grant of 118.5296 Deferred Stock Units tied to Company common stock. Each unit represents the right to receive one share or cash, settling after employment ends or in a future year under the Executive Deferral and Stock Match Plan, bringing his reported Deferred Stock Unit holdings to 24,424.9883 units.
Scots-Knight Denise reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health director Denise Scots-Knight received equity compensation awards rather than buying shares on the market. She was granted 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity award to non-employee board members.
Following these grants, her directly held common stock and stock-based awards reported in the filing total 105,588 shares for one award category and 93,392 shares for the other. These awards were granted at no cash cost per unit, reflecting standard board compensation in stock-based form.
Kurzius Lawrence Erik reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc director Lawrence Erik Kurzius reported two equity awards of common stock on May 21, 2026. He received 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity grant for non-employee directors.
Both awards were recorded at $0.00 per share, reflecting compensation grants rather than open-market purchases.
McDonald Kirk P reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health director Kirk P. McDonald received equity compensation rather than buying shares on the market. He was granted 12,196 deferred stock units as a pro-rated annual award and 4,678 restricted stock units as an annual equity award for non-employee directors. Following these grants, the filing shows direct holdings of 105,588 and 93,392 common shares tied to the respective awards.
Elanco Animal Health director Paul Herendeen reported two equity awards in the form of common stock-based units. On May 21, 2026, he acquired 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity award for non-employee Board members. These are compensation-related grants at no cash cost to him, not open-market purchases or sales, and increase his equity-based stake in Elanco.
Elanco Animal Health director Deborah Turner Kochevar received an equity award of 4,678 shares of common stock on May 21, 2026. The Form 4 labels this as a grant or award acquisition at no cost per share, reported as a grant of deferred stock units for non-employee Board members. Following the award, she directly owns 94,392 shares of Elanco common stock. This is a routine director compensation grant rather than an open-market purchase.
HOOVER R DAVID reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc director R. David Hoover received a grant of 4,678 shares of Common Stock as deferred stock units, described as a pro-rated annual equity award for non-employee board members. The award carried a grant price of $0.00 per share, reflecting its compensation nature rather than a market purchase.
After this grant, Hoover directly holds 111,451 shares of Elanco common stock. He also has indirect holdings reported through the Suzanne A. Hoover Revocable Trust with 15,920 shares and another Revocable Trust with 150,000 shares, providing additional indirect exposure to Elanco shares.
Harrington Michael J reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health director Michael J. Harrington reported equity awards of common stock on May 21, 2026. He received 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity award for non-employee board members, both at no cash cost.
Anand Kapila K reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health director Anand K. Kapila received equity compensation, not making any open-market trades. On May 21, 2026, he was granted 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity award for non-employee directors. Both awards were recorded at $0.00 per share, reflecting stock-based compensation rather than a purchase. After these grants, the filing reports his direct ownership of Elanco common stock at 111,847 shares.